Overall rank by patents
#47,627
of 49,997 tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 2 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G02B (Optical Elements, Systems OR Apparatus).
The verdict
According to USPTO PatentsView, Immy ranks #47,627 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 2 technology areas.
USPTO PatentsView assignee plate
Corpus R47627 · US Corporation #47,627 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Immudex ApS (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Qingdao Ecopure Filter · near
26 score
QuSpin · near
26 score
Immy · this assignee
26 score
Magma Giessereitechn… · near
26 score
Meril Life Sciences… · near
26 score
3D Lighting… · lowest
7 score
What this shows Immy's Innovation Score is 26.2/100 (20th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Immy Inc. is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under G02B (Optical Elements, Systems OR Apparatus). Peak complete grant year is 2016 (2 grants) versus a trough of 1 in 2015. By volume, Immy sits between Immudex ApS and Incanthera Ltd.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Immudex ApS
5 patents
ImmunGene Inc
5 patents
ImmunoMolecular Therapeutics, Inc.
5 patents
Immunology Laboratories, Inc.
5 patents
Impact Solutions
5 patents
In The Black Revocable Trust
5 patents
InTunes Products, LLC
5 patents
Incanthera Ltd
5 patents
Immy Inc.
5 patents
What this shows Immy holds 5 patents at rank #47,766, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #47,766 in granted patent volume.
Other assignees with the most granted patents in Immy's primary technology class.
Two PlainPatent-derived peer sets for Immy, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (26 here).
Immy's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
26 20th percentile higher than 20% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 20.0% |
| 2016 | 2 | 40.0% |
| 2018 | 1 | 20.0% |
| 2021 | 1 | 20.0% |
Top 2 of 2 technology areas
Overall rank by patents
#47,627
of 49,997 tracked assignees
26.2 out of 100
What to do with this data
Immy Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.